The analysis found no statistically significant increase in overall cancer risk, with a pooled risk ratio of 0.98 (95% CI 0.83-1.15), indicating similar cancer rates between GLP-1-treated patients and control groups
I am so happy I found this company
For many of our patients in their 40s, 50s, and 60s, a large portion of our patient population, hormone optimization is not optional
Finland Research has demonstrated that Tesamorelin, in particular, targets visceral fat reduction, while Ipamorelin and CJC-1295 No DAC enhance lipolysis
The SURMOUNT-5 trial (NEJM, 2025) found that tirzepatide produced an average weight loss of 20.2% versus 13.7% for semaglutide over 72 weeks a clinically meaningful difference
[33] As another example, after we established C1748 as a device category code effective July 1, 2020, we updated the list of procedure codes (HCPCS codes 43260 through 43265 and HCPCS codes 43274, 43276 through 43278) associated with HCPCS code C1748 in 2022 to include transnasal services (HCPCS codes 0652T, 0653T, 0654T, 43197, and 43198)
